Structure |
Chemical Name |
CAS |
MF |
![1-[2-amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol](/CAS/GIF/149289-29-2.gif) |
1-[2-amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol |
149289-29-2 |
C14H21NO2 |
![(E)-1-(3-ピリジル)-3-ジメチルアミノ-2-プロペン-1-オン](/CAS2/GIF/123367-26-0.gif) |
(E)-1-(3-ピリジル)-3-ジメチルアミノ-2-プロペン-1-オン |
123367-26-0 |
C10H12N2O |
![(R)-8-(ベンジルオキシ)-5-(オキシラン-2-イル)キノリン-2(1H)-オン](/CAS2/GIF/173140-90-4.gif) |
(R)-8-(ベンジルオキシ)-5-(オキシラン-2-イル)キノリン-2(1H)-オン |
173140-90-4 |
C18H15NO3 |
![3-Dechloro Sertraline Hydrochloride](/CAS/20150408/GIF/79646-00-7.gif) |
3-Dechloro Sertraline Hydrochloride |
79646-00-7 |
C17H19Cl2N |
![7-DeMethyl Ivabradine](/CAS/GIF/304462-60-0.gif) |
7-DeMethyl Ivabradine |
304462-60-0 |
C26H34N2O5 |
![8-Dechloro-9-chloro Loratadine](/CAS/GIF/109537-11-3.gif) |
8-Dechloro-9-chloro Loratadine |
109537-11-3 |
C22H23ClN2O2 |
![N-エチル-L-バリン酸アシクロビル塩酸塩](/CAS/GIF/1346617-49-9.gif) |
N-エチル-L-バリン酸アシクロビル塩酸塩 |
1346617-49-9 |
C15H25ClN6O4 |
![AMikacin B](/CAS/GIF/48237-20-3.gif) |
AMikacin B |
48237-20-3 |
C22H44N6O12 |
![Carboxy Gliclazide](/CAS/GIF/38173-52-3.gif) |
Carboxy Gliclazide |
38173-52-3 |
C15H19N3O5S |
![Dehydro RifaxiMin](/CAS/GIF/80621-76-7.gif) |
Dehydro RifaxiMin |
80621-76-7 |
C43H49N3O11 |
![N,N'-Desethylene Levofloxacin Hydrochloride](/CAS/20140608/GIF/CB72543906.gif) |
N,N'-Desethylene Levofloxacin Hydrochloride |
151250-76-9 |
C16H18FN3O4 |
![rac 3-Deacetyl-3-butanoyl Acebutolol Hydrochloride](/CAS/GIF/57898-71-2.gif) |
rac 3-Deacetyl-3-butanoyl Acebutolol Hydrochloride |
57898-71-2 |
C20H33ClN2O4 |
![rac Deoxy-O-desMethyl Venlafaxine](/CAS/20140608/GIF/CB72544099.gif) |
rac Deoxy-O-desMethyl Venlafaxine |
1346605-18-2 |
C16H25NO |
![2-Keto ZolpideM](/CAS/20180808/GIF/400038-68-8.gif) |
2-Keto ZolpideM |
400038-68-8 |
C19H19N3O2 |
![N-ForMyl Oxcarbazepine](/CAS/GIF/1346601-76-0.gif) |
N-ForMyl Oxcarbazepine |
1346601-76-0 |
C16H12N2O3 |
![OseltaMivir Acid Methyl Ester](/CAS/GIF/208720-71-2.gif) |
OseltaMivir Acid Methyl Ester |
208720-71-2 |
C15H26N2O4 |
![2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide](/CAS/20140608/GIF/CB72551435.gif) |
2'-[(1E)-2-[4-[[(2-carboxyethyl)aMino]carbonyl]phenyl]diazenyl] Balsalazide |
1346606-53-8 |
C27H24N6O9 |
![7β-Fulvestrant](/CAS/GIF/407577-53-1.gif) |
7β-Fulvestrant |
407577-53-1 |
C32H47F5O3S |
![DANTROLENE RELATED COMPOUND B (5-(4ニトロフェニル)-2-フルアルデヒド-(2-カルボキシメチル)セミカルバゾン)](/CAS/20150408/GIF/57268-33-4.gif) |
DANTROLENE RELATED COMPOUND B (5-(4ニトロフェニル)-2-フルアルデヒド-(2-カルボキシメチル)セミカルバゾン) |
57268-33-4 |
C14H12N4O6 |
![ドキサゾシン関連化合物F (N,N'-ビス(1,4-ベンゾジオキサン-2-カルボニル)ピペラジン)](/CAS/20150408/GIF/617677-53-9.gif) |
ドキサゾシン関連化合物F (N,N'-ビス(1,4-ベンゾジオキサン-2-カルボニル)ピペラジン) |
617677-53-9 |
C22H22N2O6 |
![Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride)](/CAS/GIF/67775-97-7.gif) |
Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) |
67775-97-7 |
C17H27ClN2O2 |
![Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-](/CAS/20150408/GIF/1255529-23-7.gif) |
Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]- |
1255529-23-7 |
C24H30ClN7O4S |
![2-[(3S)-キヌクリジン-3-イル]-2,4,5,6-テトラヒドロ-1H-ベンゾ[de]イソキノリン-1-オン](/CAS/GIF/135729-56-5.gif) |
2-[(3S)-キヌクリジン-3-イル]-2,4,5,6-テトラヒドロ-1H-ベンゾ[de]イソキノリン-1-オン |
135729-56-5 |
C19H22N2O |
![EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]-](/CAS/GIF/1255529-25-9.gif) |
EthanediaMide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2S,4S)-4-[(diMethylaMino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-Methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]aMino]cyclohexyl]- |
1255529-25-9 |
C24H30ClN7O4S |
![N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/20130318/GIF/CB72601888.gif) |
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-2-chloro-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
923036-25-3 |
C20H24ClN5 |
![8-クロロ-11-(ピペリジン-4-イリデン)-11H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン](/CAS/20150408/GIF/117811-20-8.gif) |
8-クロロ-11-(ピペリジン-4-イリデン)-11H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン |
117811-20-8 |
C19H17ClN2 |
![Fludarabine Phosphate iMpurity B](/CAS/20180808/GIF/149297-79-0.gif) |
Fludarabine Phosphate iMpurity B |
149297-79-0 |
C5H5N5O |
![nifedipine iMpurity C](/CAS/20130318/GIF/CB72610819.gif) |
nifedipine iMpurity C |
111304-31-5 |
C12H11NO5 |
![N-(3,5-ジクロロ-4-ピリジル)-3-(シクロプロピルメトキシ)-4-ヒドロキシベンズアミド](/CAS/GIF/475271-62-6.gif) |
N-(3,5-ジクロロ-4-ピリジル)-3-(シクロプロピルメトキシ)-4-ヒドロキシベンズアミド |
475271-62-6 |
C16H14Cl2N2O3 |
![Ritonavir EP Impurity I](/CAS/GIF/165315-26-4.gif) |
Ritonavir EP Impurity I |
165315-26-4 |
C36H46N6O5S2 |
![7-アドカピバルアミド](/CAS/GIF/146794-70-9.gif) |
7-アドカピバルアミド |
146794-70-9 |
C13H18N2O4S |
![3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one](/CAS/GIF/1086026-31-4.gif) |
3-[3-[[[(7S)-3,4-DiMethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]Methyl]MethylaMino]propyl]-1,3-dihydro-7,8-diMethoxy-H-3-benzazepin-2-one |
1086026-31-4 |
C27H34N2O5 |
![7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine](/CAS/20130318/GIF/CB72621905.gif) |
7-[(3R)-3-[(N-Acetyl)AMino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoroMethyl)-1,2,4-triazolo[4,3-a]pyrazine |
1379666-94-0 |
C18H17F6N5O2 |
![(S)-ズロキセチンフタルアミド](/CAS/GIF/199191-67-8.gif) |
(S)-ズロキセチンフタルアミド |
199191-67-8 |
C26H23NO4S |
![Labetalol IMpurity B](/CAS/20150408/GIF/802620-01-5.gif) |
Labetalol IMpurity B |
802620-01-5 |
C20H25NO4 |
![N-[(1S,2S,4S)-4-(アセチルアミノ)-1-ベンジル-2-ヒドロキシ-5-フェニルペンチル]カルバミン酸1,3-チアゾール-5-イルメチル](/CAS/GIF/1010808-43-1.gif) |
N-[(1S,2S,4S)-4-(アセチルアミノ)-1-ベンジル-2-ヒドロキシ-5-フェニルペンチル]カルバミン酸1,3-チアゾール-5-イルメチル |
1010808-43-1 |
C25H29N3O4S |
![(S)-キヌクリジン-3-アミン](/CAS/GIF/120570-05-0.gif) |
(S)-キヌクリジン-3-アミン |
120570-05-0 |
C7H14N2 |
![Benzene, 1-chloro-2-nitroso-](/CAS/GIF/932-33-2.gif) |
Benzene, 1-chloro-2-nitroso- |
932-33-2 |
C6H4ClNO |
![IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate](/CAS/20200611/GIF/38092-95-4.gif) |
IMp. A (EP): Ethyl 4-[(11RS)-8-Chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate |
38092-95-4 |
C19H20N2 |
![PeMetrexed EP IMpurity E](/CAS/20180906/GIF/182009-04-7.gif) |
PeMetrexed EP IMpurity E |
182009-04-7 |
C20H21N5O6 |
![Itraconazole iMpurity A](/) |
Itraconazole iMpurity A |
|
|
![(S)-BoroLeu-(-)-Pinanediol-CF3COOH](/CAS/20180808/GIF/477254-69-6.gif) |
(S)-BoroLeu-(-)-Pinanediol-CF3COOH |
477254-69-6 |
C17H29BF3NO4 |
![Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester](/CAS/GIF/3333-46-8.gif) |
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester |
3333-46-8 |
C5H8O6 |
![バルサルタン-D9 (MAJOR)](/CAS/GIF/1089736-73-1.gif) |
バルサルタン-D9 (MAJOR) |
1089736-73-1 |
C24H29N5O3 |
![(E)-4-(2-(1-(m-tolyl)ethylidene)hydrazinyl)benzenesulfonamide](/CAS/20200401/GIF/CB74842582.gif) |
(E)-4-(2-(1-(m-tolyl)ethylidene)hydrazinyl)benzenesulfonamide |
|
C15H17N3O2S |
![Gefitinib impurity M](/) |
Gefitinib impurity M |
|
|
![Linagliptin Impurity CD10088](/) |
Linagliptin Impurity CD10088 |
|
|
![Tacrolimus Ring-opening Impurity](/CAS/20211123/GIF/1393890-33-9.gif) |
Tacrolimus Ring-opening Impurity |
1393890-33-9 |
C44H69NO12 |
![Tadalafil Impurity 35](/CAS/20210111/GIF/749864-17-3.gif) |
Tadalafil Impurity 35 |
749864-17-3 |
C20H18N2O4 |
![Epinastine Impurity 1 HCl](/CAS/20210111/GIF/141342-71-4.gif) |
Epinastine Impurity 1 HCl |
141342-71-4 |
C15H15N3O2 |
![Flurbiprofen Impurity 5](/CAS/20211123/GIF/124635-84-3.gif) |
Flurbiprofen Impurity 5 |
124635-84-3 |
C18H19FO4 |
![Diazepam Impurity 3](/CAS/20200611/GIF/176796-46-6.gif) |
Diazepam Impurity 3 |
176796-46-6 |
C17H17ClN2O2 |
![Pitavastatin Impurity 19 Sodium Salt](/CAS/20210111/GIF/1980814-87-6.gif) |
Pitavastatin Impurity 19 Sodium Salt |
1980814-87-6 |
C25H24FNO5 |
![N-(4-(4-fluorophenyl)-5-((E)-2-((2R,4R)-4-hydroxy-6- oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin- 2-yl)-N-methylmethanesulfonamide](/CAS/20200401/GIF/CB74849839.gif) |
N-(4-(4-fluorophenyl)-5-((E)-2-((2R,4R)-4-hydroxy-6- oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin- 2-yl)-N-methylmethanesulfonamide |
|
C22H26FN3O5S |
![Fulvestrant EP Impurity E](/CAS/20211123/GIF/2170200-14-1.gif) |
Fulvestrant EP Impurity E |
2170200-14-1 |
C32H45F5O3S |
![Edaravone Impurity 16](/) |
Edaravone Impurity 16 |
|
|
![Linagliptin Impurity 50](/) |
Linagliptin Impurity 50 |
|
|
![Phenacetin Impurity 3](/CAS/20200401/GIF/24176-84-9.gif) |
Phenacetin Impurity 3 |
24176-84-9 |
C14H13ClN2O2 |
![2-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-1-ol](/CAS/20200401/GIF/109632-11-3.gif) |
2-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-1-ol |
109632-11-3 |
C15H25NO3 |
![Pabuxilibu impurities](/) |
Pabuxilibu impurities |
|
|
![ERYTHROMYCIN IMPURITY G](/) |
ERYTHROMYCIN IMPURITY G |
|
|
![Amylmetacresol EP impurity E](/) |
Amylmetacresol EP impurity E |
|
|
![(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide](/CAS/20200401/GIF/2232201-72-6.gif) |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide |
2232201-72-6 |
C11H18N2O3 |
![methyl 1-hydroxy-2-oxoindoline-6-carboxylate](/CAS/20200401/GIF/1895918-24-7.gif) |
methyl 1-hydroxy-2-oxoindoline-6-carboxylate |
1895918-24-7 |
C10H9NO4 |
![Dapagliflozin Impurity (MW: 437Da)](/) |
Dapagliflozin Impurity (MW: 437Da) |
|
|
![Cetirizine Impurity BHA](/) |
Cetirizine Impurity BHA |
|
|
![Cilastatin EP Impurity H](/) |
Cilastatin EP Impurity H |
|
|
![Febuxostat Impurity 130](/CAS/20200515/GIF/1643131-93-4.gif) |
Febuxostat Impurity 130 |
1643131-93-4 |
C20H25NO5S |
![(2-Chlorophenyl)diphenylmethanol](/) |
(2-Chlorophenyl)diphenylmethanol |
|
|
![Nilotinib Impurity 27](/CAS/20210111/GIF/1807606-80-9.gif) |
Nilotinib Impurity 27 |
1807606-80-9 |
C28H22F3N7O2 |
![Vonoprazan Impurity 53](/) |
Vonoprazan Impurity 53 |
|
|
![Vonoprazan Impurity 61](/) |
Vonoprazan Impurity 61 |
|
|
![Emtricitabine Ring-opening Impurity](/) |
Emtricitabine Ring-opening Impurity |
|
|
![Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer)](/) |
Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer) |
|
|
![Escitalopram Butyryl Impurity](/CAS/20210111/GIF/1803244-58-7.gif) |
Escitalopram Butyryl Impurity |
1803244-58-7 |
C25H33FN2O2 |
![Oseltamivir isomer impurity](/) |
Oseltamivir isomer impurity |
|
|
![SULPIRIDE IMPURITY B](/) |
SULPIRIDE IMPURITY B |
|
|
![1,2-Dihydro Diethyl Loteprednol Carbonate](/) |
1,2-Dihydro Diethyl Loteprednol Carbonate |
82048-81-5 |
C26H36O9 |
![Nilotinib 3-Imidazolyl N-oxide](/CAS/20210111/GIF/2139382-75-3.gif) |
Nilotinib 3-Imidazolyl N-oxide |
2139382-75-3 |
C28H22F3N7O2 |
![α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol](/) |
α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol |
857786-66-4 |
C19H25NO2 |
![Pramipexole 828 Impurity](/) |
Pramipexole 828 Impurity |
|
|
![E-Ceftazidime Oxide Impurity](/) |
E-Ceftazidime Oxide Impurity |
|
|
![Cefuroxime Impurity D Δ3-Isomer](/) |
Cefuroxime Impurity D Δ3-Isomer |
|
|
![Ampicillin Open-Ring Formylation Impurity](/) |
Ampicillin Open-Ring Formylation Impurity |
|
|
![Faropenem Degradation Impurity A](/) |
Faropenem Degradation Impurity A |
|
|
![2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid](/) |
2-(5-hydroxy-5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid |
|
|
![(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate](/) |
(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate |
|
|
![(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole](/) |
(E)-1-(2,4-difluorostyryl)-1H-1,2,4-triazole |
|
|
![Peramivir Impurity 22](/) |
Peramivir Impurity 22 |
|
|
![Olaparib Impurity 58](/CAS/20210111/GIF/848136-41-4.gif) |
Olaparib Impurity 58 |
848136-41-4 |
C22H21FN4O3 |
![Fluconazole Impurity 4](/CAS/20210111/GIF/168479-96-7.gif) |
Fluconazole Impurity 4 |
168479-96-7 |
C10H7F2N3O |
![Roxatidine Impurity 7](/CAS/20210111/GIF/876497-65-3.gif) |
Roxatidine Impurity 7 |
876497-65-3 |
C7H6N2O2 |
![Sparfloxacin Impurity](/CAS/20210111/GIF/126457-99-6.gif) |
Sparfloxacin Impurity |
126457-99-6 |
C19H21F2N3O3 |
![Peramivir Impurity 39](/) |
Peramivir Impurity 39 |
|
|
![Imatinib impurity 39](/) |
Imatinib impurity 39 |
|
|
![7-(4-ブロモブトキシ)キノリン-2(1H)-オン](/StructureFile/ChemBookStructure22/GIF/CB7648430.gif) |
7-(4-ブロモブトキシ)キノリン-2(1H)-オン |
203395-59-9 |
C13H14BrNO2 |
![DESMETHYL ATOMOXETINE HYDROCHLORIDE](/CAS/GIF/881995-46-6.gif) |
DESMETHYL ATOMOXETINE HYDROCHLORIDE |
881995-46-6 |
C16H19NO.ClH |
![2-ヒドロキシ-5-ベンジルオキシアセトフェノン](/CAS/GIF/30992-63-3.gif) |
2-ヒドロキシ-5-ベンジルオキシアセトフェノン |
30992-63-3 |
C15H14O3 |
![2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE](/CAS/GIF/102804-82-0.gif) |
2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLE |
102804-82-0 |
C15H15N3OS |
![2-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZONITRILE](/CAS/GIF/864069-00-1.gif) |
2-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZONITRILE |
864069-00-1 |
C13H17N3 |